Overexpression of anti‐apoptotic BCL2 family members contributes to the development of hematological malignancies including MM,37, 38 CLL,39 acute myeloid leukemia,40 and non‐Hodgkin's lymphoma.41 This evidence concerns the gene BCL2 and acute myeloid leukemia.